Paper7350806
Tuberculosis in patients with end-stage renal disease.
Andrew OT and 3 others. Am J Med, 1980. Cited by 234 papers, by iCite.
Cite this record
ConductScience Library. Tuberculosis in patients with end-stage renal disease. Papers, record 7350806. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7350806
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Kidney Failure, Chronic | Major topic |
| Tuberculosis | Major topic |
| Adult | |
| Aged | |
| Ethambutol | |
| Female | |
| Humans | |
| Immunity, Cellular | |
| Isoniazid | |
| Male | |
| Middle Aged | |
| Pyrazinamide | |
| Renal Dialysis | |
| Rifampin | |
| Risk |
Source PubMed
Cited by31
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 234 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42638763 | The role of the immune response in developing tuberculosis infection: from latent infection to active tuberculosis. | Front Tuberc | 2024 | https://conductscience.org/library/papers/42638763 | PubMed |
| 42443805 | Association between maintenance dialysis and tuberculosis treatment outcomes in Amazonas, Brazil: a population-based record-linkage cohort study (2001-2023) : Maintenance Dialysis and Tuberculosis Outcomes. | BMC Infect Dis | 2026 | https://conductscience.org/library/papers/42443805 | PubMed |
| 34870127 | A rare localization of tuberculosis under infliximab treatment: Testicular involvement. | Turk J Phys Med Rehabil | 2021 | https://conductscience.org/library/papers/34870127 | PubMed |
| 34786244 | Transudative and Exudative Pleural Effusion in Chronic Kidney Disease Patients: A Prospective Single-Center Study. | Cureus | 2021 | https://conductscience.org/library/papers/34786244 | PubMed |
| 30212930 | Gene co-expression network analysis identifies the hub genes associated with immune functions for nocturnal hemodialysis in patients with end-stage renal disease. | Medicine (Baltimore) | 2018 | https://conductscience.org/library/papers/30212930 | PubMed |
| 27795624 | Rifampicin and anti-hypertensive drugs in chronic kidney disease: Pharmacokinetic interactions and their clinical impact. | Indian J Nephrol | 2016 | https://conductscience.org/library/papers/27795624 | PubMed |
| 27168859 | Predictive value of the tuberculin skin test and QuantiFERON-tuberculosis Gold In-Tube test for development of active tuberculosis in hemodialysis patients. | Ann Thorac Med | 2016 | https://conductscience.org/library/papers/27168859 | PubMed |
| 26839146 | Updates on the risk factors for latent tuberculosis reactivation and their managements. | Emerg Microbes Infect | 2016 | https://conductscience.org/library/papers/26839146 | PubMed |
| 24049269 | Tuberculosis in haemodialysis patients: A single centre experience. | Indian J Nephrol | 2013 | https://conductscience.org/library/papers/24049269 | PubMed |
| 23510593 | Increased risk of tuberculosis in patients with end-stage renal disease: a population-based cohort study in Taiwan, a country of high incidence of end-stage renal disease. | Epidemiol Infect | 2014 | https://conductscience.org/library/papers/23510593 | PubMed |
| 23143752 | Mycobacterium tuberculous peritonitis in CAPD patients: a report of 11 patients and review of literature. | Int Urol Nephrol | 2013 | https://conductscience.org/library/papers/23143752 | PubMed |
| 20634392 | Tuberculosis: evidence review for newly arriving immigrants and refugees. | CMAJ | 2011 | https://conductscience.org/library/papers/20634392 | PubMed |
| 20103957 | Saudi guidelines for testing and treatment of latent tuberculosis infection. | Ann Saudi Med | 2010 | https://conductscience.org/library/papers/20103957 | PubMed |
| 19139810 | High prevalence of latent tuberculosis infection in patients in end-stage renal disease on hemodialysis: Comparison of QuantiFERON-TB GOLD, ELISPOT, and tuberculin skin test. | Infection | 2009 | https://conductscience.org/library/papers/19139810 | PubMed |
| 18550653 | Interferon-gamma release assays for diagnosing mycobacterium tuberculosis infection in renal dialysis patients. | Clin J Am Soc Nephrol | 2008 | https://conductscience.org/library/papers/18550653 | PubMed |
| 16809417 | Empirical treatment with a fluoroquinolone delays the treatment for tuberculosis and is associated with a poor prognosis in endemic areas. | Thorax | 2006 | https://conductscience.org/library/papers/16809417 | PubMed |
| 16443149 | The management of respiratory infections during pregnancy. | Immunol Allergy Clin North Am | 2006 | https://conductscience.org/library/papers/16443149 | PubMed |
| 15762766 | Pharmacokinetic considerations in the treatment of tuberculosis in patients with renal failure. | Clin Pharmacokinet | 2005 | https://conductscience.org/library/papers/15762766 | PubMed |
| 15461815 | Tuberculous peritonitis in a case receiving continuous ambulatory peritoneal dialysis(CAPD) treatment. | Ann Clin Microbiol Antimicrob | 2004 | https://conductscience.org/library/papers/15461815 | PubMed |
| 15218960 | Tuberculosis-associated hemophagocytic syndrome in a hemodialysis patient with protracted fever. | Int J Hematol | 2004 | https://conductscience.org/library/papers/15218960 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7350806
GET https://conductscience.org/api/papers/v1/7350806/cited_by?page=2